comparemela.com

Latest Breaking News On - Syncona limited stock exchange - Page 1 : comparemela.com

Syncona : Full Year Results for the 12 months ended 31 March 2023

Syncona Ltd, a leading healthcare company focused on creating, building and scaling a portfolio of global leaders in life science, today announces its Annual Results for the 12 months ended. | June 15, 2023

Chris hollowoodSyncona ltdAdvisory groupSyncona investment managementAnnual resultsBeacon therapeuticsInterim resultsAutolu nucleusBeacon therapeuticX linked retinitis pigmentosaSwanbio therapeuticsSyncona investment management limitedSyncona limited stock exchangePress releaseOnths bact gg00b8p59c08

Syncona investee Freeline swings to first-quarter profit

Syncona Ltd - London-based investor in healthcare companies - Reports first-quarter results of investee Freeline Therapeutics Holdings PLC. Freeline is a clinical-stage biotechnology company.. | May 30, 2023

City ofUnited kingdomMichael pariniAlliance newsAlliance news ltdFreeline therapeutics holdingsSyncona ltdExecutive officer michael pariniWill neillAll rightsSyncona limited stock exchangePress releaseIotechnology bact gg00b8p59c08

Syncona : OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension

Jim Geraghty joins as Independent Director and Chair, bringing US and international experience from Genzyme and as NED and chair of multiple listed biotechs British Patient. | May 15, 2023

United kingdomJames jim geraghtyJim geraghtyGenzyme europeRos deeganCarol robinsonRosamond deeganYale law schoolOxford science enterprisesCanbridge pharmaceuticalsBusiness development at sanofiPrudential regulation authorityBritish patient capitalConsilium strategic communicationsFinancial conduct authorityBritish business bank

Syncona say portfolio clinical company Achilles have widened losses

Syncona Ltd on Wednesday said that its portfolio company Achilles Therapeutics PLC has made losses in the first quarter of 2023, with cash equivalents falling and expenses increasing. Syncona is a. | May 10, 2023

City ofUnited kingdomMiraj aliSyncona ltd onAlliance news ltdAlliance newsAchilles therapeuticsAchilles chief executive officer irajNew yorkWill neillAll rightsSyncona limited stock exchangePress releaseS bact gg00b8p59c08

Syncona : OMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progress

Move to new purpose-built 16,000ft2 flagship site on ARC Oxford campus to support continued company growth Expansion of senior leadership team with the appointment of Winfried. | April 19, 2023

United kingdomNordrhein westfalenDavid williamsRosamond deeganRos deeganUniversity of bonnGerman centre for infection researchConsilium strategic communicationsOxford science enterprisesVice presidentExecutive directorInnate immunityTranslational immunologyGerman centreChief executive officerNorthpond ventures

vimarsana © 2020. All Rights Reserved.